LoginSign Up
Juventus Therapeutics

Juventus Therapeutics

Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.

Juventas Therapeutics is a biotechnology company developing non-viral gene therapies capable of activating natural processes within the body for healing and repair. The company was founded by Rahul Aras in 2007 and is headquartered in Cleveland, Ohio.

Their first therapeutic product candidate JVS-100 is a non-viral gene therapy expressing a signalling protein that can recruit naturally occurring stem cells and promote tissue repair in a broad range of disease states. Juventas is currently completing a Phase 2b study with JVS-100 in patients with advanced peripheral artery disease.

Timeline

People

Name
Role
Related Golden topics

Joseph Pastore

Senior Vice President, Clinical Product Development

Mathew Pollman

Chief Medical Officer

Michael Fitzgerald

Vice President, Clinical Operations

Rahul Aras

Co-Founder, President, & CEO

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References